1stabirateroneacademicacceleratedadcsadjuvantadvancedandreaantibodyapcccapproachesapprovalarpiascoasco24atezolizumabauaavelumabbcgbelzutifanbiomarkerbiomarkersbispecificbladderbonecabocabozantinibcanariascanarycancercancerscarcinomacareercellcheckmatechemochoueirichristmasclassificationclearclinicalcombinationsconferencecontact2cosmiccovidcrpcctdnacupcystectomydatadebatedevelopmentdirecteddiscussesdiscussingdiscussiondiseasedrugdrugsearlyeaueikcsemergencyenzaenzalutamideerdafitinibesmoevfdafgfrfinalfirstfrontfuturegalskygermgermanyguguidelineshifhighhighlightshistoryholidayhormoneiiiimmuneineligibleinhibitioninhibitorinvasiveioipiipilimumabislandsjapankeynotekidneylegendslinelivemaintenancemattmcrpcmdmeetmeetingmeetingsmetastasicometastaticmhspcmolecularmonthmrccmusclenashvilleneoadjuvantniagaranicknivonivolumabnmibcnovelodacolapariboncologyoraloverviewpaperpapillaryparpipatientspdpd1pembropembrolizumabperspectivepetphasepluspostpreviewprostateprostatectomypsmaqolradioligandsradiotherapyrccrecaprefractoryrenalresistanceresultsresumenreunionreviewrisingriskrolescoreseriessesionsessionsparingspecialstampedestarstudiesstudysummarysurgerysurveillancesurvivaltalaprotalazoparibtargetingtestistherapytomtonitoripalimabtourtreatmenttrestrialtrialstripletucunresponsiveupdateuramigasuromigosliveuromigoslive24urothelialvegfvejigaworldyear